⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SIGA News
SIGA Technologies Inc.
NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II
accessnewswire.com
NNVC
SIGA
EBS
GILD
Form 8-K
sec.gov
SIGA
SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update
globenewswire.com
SIGA
SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results
globenewswire.com
SIGA
Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides
accessnewswire.com
NNVC
GILD
SIGA
EBS
Form 8-K
sec.gov
SIGA
SIGA Declares Special Cash Dividend of $0.60 Per Share
globenewswire.com
SIGA
Form 8-K
sec.gov
SIGA
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update
globenewswire.com
SIGA
SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results
globenewswire.com
SIGA